
0.23 Delayed Data As of Feb 08 | ![]() Today’s Change | 0.14 Today|||52-Week Range 6.54 | +31.43% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $26.6M |
Rubius Therapeutics, Inc. 399 Binney Street Cambridge Massachusetts 02139 |
Dannielle Appelhans | President, Chief Executive & Financial Officer |
Spencer Fisk | Chief Technical Operations |
Mark Hernon | Chief Information Officer |
Theo Proukou | Chief People Officer & Senior Vice President |
Greg Whitehead | Chief Quality Officer & Senior Vice President |